Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

SB 258719

Catalog No. T12855 Copy Product Info
Purity: 99.73%
🥰Excellent
SB 258719 is a selective antagonist of 5-HT7 receptor with pKi of 7.5.

SB 258719

Copy Product Info
🥰Excellent
Catalog No. T12855

SB 258719 is a selective antagonist of 5-HT7 receptor with pKi of 7.5.

SB 258719
Cas No. 195199-95-2
Pack SizePriceUSA StockGlobal StockQuantity
2 mg$30-In Stock
5 mg$50-In Stock
10 mg$82-In Stock
25 mg$166-In Stock
50 mg$267-In Stock
100 mg$395-In Stock
200 mg$557-In Stock
1 mL x 10 mM (in DMSO)$56-In Stock
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
Custom-made molecule. TargetMol’s expert synthesis team delivers cost-effective solutions. Contact us for inquiries. Committed to serving you.
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.73%
Appearance:Solid
Color:Transparent
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
SB 258719 is a selective antagonist of 5-HT7 receptor with pKi of 7.5.
Targets&IC50
5-HT7 receptor:7.5 (pKi)
In vitro
SB 258719 antagonised surmountably 5-CT-stimulated adenylyl cyclase activity. Schild analysis of the antagonism by SB 258719 gave a pA2 of 7.2±0.2 and slope not significantly different from 1, consistent with competitive antagonism[3].
In vivo
SB 258719 (5-20 mg/kg, i.p.) reversed the hypothermic effect of 5-CT in mice[1], attenuated increased Wnt/β-catenin activity in HCC cell lines and patient-derived primary tumor tissues in the presence of 5-HT, and reduced tumor growth in vivo[2].
Chemical Properties
Molecular Weight338.51
FormulaC18H30N2O2S
Cas No.195199-95-2
SmilesC[C@H](CCN1CCC(C)CC1)N(C)S(=O)(=O)c1cccc(C)c1
Relative Density.1.075 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 250 mg/mL (738.53 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (14.77 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.9541 mL14.7706 mL29.5412 mL147.7061 mL
5 mM0.5908 mL2.9541 mL5.9082 mL29.5412 mL
10 mM0.2954 mL1.4771 mL2.9541 mL14.7706 mL
20 mM0.1477 mL0.7385 mL1.4771 mL7.3853 mL
50 mM0.0591 mL0.2954 mL0.5908 mL2.9541 mL
100 mM0.0295 mL0.1477 mL0.2954 mL1.4771 mL
Note : The dilution table applies only to solid products. For liquid products, please calculate the stock solution based on the stated concentration and/or density.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy SB 258719 | purchase SB 258719 | SB 258719 cost | order SB 258719 | SB 258719 chemical structure | SB 258719 in vivo | SB 258719 in vitro | SB 258719 formula | SB 258719 molecular weight